Literature DB >> 32122771

Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey.

Raffaele Pezzilli1, Elisabetta Buscarini2, Tommaso Pollini3, Deborah Bonamini3, Giovanni Marchegiani3, Stefano Crippa4, Giulio Belfiori4, Cosimo Sperti5, Lucia Moletta5, Gioia Pozza5, Germana De Nucci6, Giampiero Manes6, Enzo D Mandelli6, Riccardo Casadei7, Claudio Ricci7, Saverio Alicante2, Claudia Vattiato2, Silvia Carrara8, Milena Di Leo8, Carlo Fabbri9, Silvia Giovanelli10, Luca Barresi11, Matteo Tacelli11, Vincenzo G Mirante12, Rita Conigliaro12, Filippo Antonini13, Giampiero Macarri13, Luca Frulloni14, Giulia De Marchi14, Romano Sassatelli15, Paolo Cecinato15, Giovanna Del Vecchio Blanco16, Andrea Galli17, Angelo Pezzullo18, Alberto Fantin19, Massimo Graffeo20, Mauro Frego21, Domenico Stillittano22, Fabio Monica23, Bastianello Germanà24, Gabriele Capurso25, Mariano Quartini26, Luigi Veneroni27, Renato Cannizzaro28, Massimo Falconi4.   

Abstract

INTRODUCTION: A prospective survey to evaluate the diagnostic workup of cystic pancreatic neoplasms (CPNs) according to the Italian guidelines.
METHODS: An online data sheet was built.
RESULTS: Fifteen of the 1385 patients (1.1%) had non cystic neoplastic lesions. Forty percent (518/1295) had at least one 1st degree relative affected by a solid tumor of the digestive and extra-digestive organs. Symptoms/signs associated with the cystic lesion were present in 24.5% of the patients. The cysts were localized in the head of the pancreas in 38.5% of patients. Of the 2370 examinations (1.7 examinations per patient) which were carried out for the diagnosis, magnetic resonance imaging was performed as a single test in 48.4% of patients and in combination with endoscopic ultrasound in 27% of the cases. Of the 1370 patients having CPNs, 89.9% had an intraductal papillary mucinous neoplasm (IPMN) (70.1% a branch duct IPMN, 6.2% a mixed type IPMN and 4.6% a main duct IPMN), 12.7% had a serous cystadenoma, 2.8% a mucinous cystadenoma, 1.5% a non-functioning cystic neuroendocrine neoplasm, 0.7% a solid-pseudopapillary cystic neoplasm, 0.3% a cystic adenocarcinoma, and 1.2% an undetermined cystic neoplasm. Seventy-eight (5.7%) patients were operated upon after the initial work-up.
CONCLUSIONS: This prospective study offers a reliable real-life picture of the diagnostic work-up CPN.
Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Cystic neoplasm; Cytology; Endosonography; Epidemiology; Magnetic resonance imaging; Multidetector computed tomography; Pancreatic cyst

Mesh:

Year:  2020        PMID: 32122771     DOI: 10.1016/j.dld.2020.02.003

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  6 in total

1.  Machine learning principles applied to CT radiomics to predict mucinous pancreatic cysts.

Authors:  Adam M Awe; Michael M Vanden Heuvel; Tianyuan Yuan; Victoria R Rendell; Mingren Shen; Agrima Kampani; Shanchao Liang; Dane D Morgan; Emily R Winslow; Meghan G Lubner
Journal:  Abdom Radiol (NY)       Date:  2021-10-12

2.  Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms.

Authors:  Tommaso Innocenti; Ginevra Danti; Erica Nicola Lynch; Gabriele Dragoni; Matteo Gottin; Filippo Fedeli; Daniele Palatresi; Maria Rosa Biagini; Stefano Milani; Vittorio Miele; Andrea Galli
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

Review 3.  Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification.

Authors:  Vincenzo Nasca; Marta Chiaravalli; Geny Piro; Annachiara Esposito; Lisa Salvatore; Giampaolo Tortora; Vincenzo Corbo; Carmine Carbone
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

Review 4.  Cystic Neoplasms of the Pancreas: Differential Diagnosis and Radiology Correlation.

Authors:  Feixiang Hu; Yue Hu; Dan Wang; Xiaowen Ma; Yali Yue; Wei Tang; Wei Liu; Puye Wu; Weijun Peng; Tong Tong
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

Review 5.  Advances in the Diagnosis of Pancreatic Cystic Lesions.

Authors:  Claudia Irina Pușcașu; Mihai Rimbaş; Radu Bogdan Mateescu; Alberto Larghi; Victor Cauni
Journal:  Diagnostics (Basel)       Date:  2022-07-22

6.  Therapeutic experience of a pancreatic mixed serous neuroendocrine neoplasm invading peripancreatic vessels: A case report.

Authors:  Zongming Zhang; Limin Liu; Youwei Li; Zhuo Liu; Chong Zhang; Yue Zhao; Mingwen Zhu; Baijiang Wan; Hai Deng; Xiyuan Xie; Kun Tian; Zhentian Guo; Haiyan Yang; Jiahong Liao; Hongyan Zhu; Lili Liu; Man Wang; Xiaoting Ma; Tiantian Liu; Niuniu Huang; Yujiao Gao; Jing Zhao; Fang Liao; Fengyuan Li; Xueting Wang; Ruijiao Yuan; Xinying Liu; Lidan Chang
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.